In:
Kidney and Blood Pressure Research, S. Karger AG, Vol. 33, No. 1 ( 2010), p. 7-14
Abstract:
〈 i 〉 Background/Aims: 〈 /i 〉 Protocol biopsies offer new possibilities to predict kidney allograft outcome. The aim of this study was to find clinical, laboratory, morphological and molecular predictors of short-term renal graft survival. 〈 i 〉 Methods: 〈 /i 〉 Three-month protocol kidney graft biopsy was carried out on 257 patients. The real-time RT-PCR was used to identify intragraft mRNA expression of several cytokines and chemokines and predictive statistics was performed to find markers connected with the risk of premature graft failure. 〈 i 〉 Results: 〈 /i 〉 Compared to patients with normal morphology at 3 months, patients with subclinical rejection including borderline changes had experienced more frequent (p 〈 0.001) acute rejections before 3-month biopsy, serum creatinine ≧170 µmol/l (p 〈 0.01), and higher intrarenal expression of RANTES, IP-10 (p 〈 0.001), C3, CD3, IgJ (p 〈 0.01) and CD20 (p 〈 0.05). There was a significant correlation between subclinical rejection and the occurrence of late acute rejection and graft failure at the first year after transplantation. Moreover, higher RANTES and IP-10 expressions in subclinical rejection predicted graft loss at one year after transplantation in the univariate analysis. 〈 i 〉 Conclusions: 〈 /i 〉 Patients with subclinical rejection including borderline changes in 3-month biopsy and particularly those with higher intrarenal expression of RANTES and IP-10 mRNA were found to be at risk for premature kidney graft loss.
Type of Medium:
Online Resource
ISSN:
1420-4096
,
1423-0143
Language:
English
Publisher:
S. Karger AG
Publication Date:
2010
detail.hit.zdb_id:
1482922-8
Bookmarklink